ECDC press release
The European Centre for Disease Prevention and Control (ECDC) has published public health considerations regarding the use of doxycycline post-exposure prophylaxis, commonly known as doxy-PEP, for the prevention of bacterial sexually transmitted infections (STIs). The guidance provides public health considerations on the use of doxy-PEP amidst the ongoing rise in bacterial STIs across the European Union and European Economic Area (EU/EEA).
Read the full press release here.
Access ‘Public health considerations on the use of doxycycline for post-exposure prophylaxis for bacterial sexually transmitted infections in the EU/EEA’ here.
Source : ECDC
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.